Powell D E, Thomas J H, Mandal A R, Dignam C T
J Clin Pathol. 1969 Nov;22(6):672-6. doi: 10.1136/jcp.22.6.672.
In 750 consecutive assays of serum vitamin B(12) levels using Lactobacillus leichmanii, 25 (3.3%) showed inhibition. A satisfactory history of drug therapy was obtained in 23 cases. Seventeen of these were receiving ampicillin at the time. Two patients showed inhibition while receiving phenoxmethyl penicillin or phenethicillin. A prospective study of 11 patients detected inhibition in seven at varying intervals during ampicillin therapy. It was shown that the vitamin B(12) as measured by the radioisotope and Euglena gracilis methods was not affected. Inhibition of L. leichmanii was reproduced in vitro with concentrations of ampicillin corresponding to those obtained in therapy. Benzylpenicillin, streptomycin, and chloramphenicol had no such effect.A prospective study of patients receiving chlorpromazine yielded negative results.Inhibition may occasionally be seen in the absence of any known intake of drugs. Measurement by other methods may be required to distinguish this from vitamin B(12) depletion.
在使用赖氏乳酸杆菌对血清维生素B12水平进行的750次连续检测中,有25次(3.3%)出现抑制现象。在23例患者中获得了满意的药物治疗史。其中17例当时正在接受氨苄西林治疗。2例患者在接受苯氧甲基青霉素或苯乙青霉素治疗时出现抑制现象。对11例患者进行的前瞻性研究发现,在氨苄西林治疗期间,有7例在不同时间段出现抑制现象。结果表明,通过放射性同位素法和纤细裸藻法测定的维生素B12不受影响。在体外,与治疗中获得的浓度相当的氨苄西林可重现对赖氏乳酸杆菌的抑制作用。苄青霉素、链霉素和氯霉素没有这种作用。对接受氯丙嗪治疗的患者进行的前瞻性研究结果为阴性。在没有任何已知药物摄入的情况下,偶尔也可能出现抑制现象。可能需要用其他方法进行检测,以将其与维生素B12缺乏区分开来。